GB201207102D0 - CRHR1 antagonists for use in the treatment of patients having CRH overactivity - Google Patents

CRHR1 antagonists for use in the treatment of patients having CRH overactivity

Info

Publication number
GB201207102D0
GB201207102D0 GBGB1207102.3A GB201207102A GB201207102D0 GB 201207102 D0 GB201207102 D0 GB 201207102D0 GB 201207102 A GB201207102 A GB 201207102A GB 201207102 D0 GB201207102 D0 GB 201207102D0
Authority
GB
United Kingdom
Prior art keywords
patients
treatment
crhr1 antagonists
crh overactivity
crh
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1207102.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HOLSBERMASCHMEYER NEUROCHEMIE GmbH
Original Assignee
HOLSBERMASCHMEYER NEUROCHEMIE GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HOLSBERMASCHMEYER NEUROCHEMIE GmbH filed Critical HOLSBERMASCHMEYER NEUROCHEMIE GmbH
Priority to GBGB1207102.3A priority Critical patent/GB201207102D0/en
Publication of GB201207102D0 publication Critical patent/GB201207102D0/en
Priority to PCT/EP2013/058413 priority patent/WO2013160317A2/en
Priority to EP13722318.6A priority patent/EP2841068B8/en
Priority to JP2015507503A priority patent/JP2015516979A/en
Priority to US14/396,617 priority patent/US20150094310A1/en
Priority to HK15107987.3A priority patent/HK1207304A1/en
Ceased legal-status Critical Current

Links

GBGB1207102.3A 2012-04-23 2012-04-23 CRHR1 antagonists for use in the treatment of patients having CRH overactivity Ceased GB201207102D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GBGB1207102.3A GB201207102D0 (en) 2012-04-23 2012-04-23 CRHR1 antagonists for use in the treatment of patients having CRH overactivity
PCT/EP2013/058413 WO2013160317A2 (en) 2012-04-23 2013-04-23 Crhr1 antagonists for use in the treatment of patients having crh overactivity
EP13722318.6A EP2841068B8 (en) 2012-04-23 2013-04-23 Crhr1 antagonists for use in the treatment of patients having crh overactivity
JP2015507503A JP2015516979A (en) 2012-04-23 2013-04-23 CRHR1 antagonists for use in treating patients with CRH overactivity
US14/396,617 US20150094310A1 (en) 2012-04-23 2013-04-23 Crhr1 antagonists for use in the treatment of patients having crh overactivity
HK15107987.3A HK1207304A1 (en) 2012-04-23 2015-08-18 Crhr1 antagonists for use in the treatment of patients having crh overactivity crh crhr1

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1207102.3A GB201207102D0 (en) 2012-04-23 2012-04-23 CRHR1 antagonists for use in the treatment of patients having CRH overactivity

Publications (1)

Publication Number Publication Date
GB201207102D0 true GB201207102D0 (en) 2012-06-06

Family

ID=46261733

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1207102.3A Ceased GB201207102D0 (en) 2012-04-23 2012-04-23 CRHR1 antagonists for use in the treatment of patients having CRH overactivity

Country Status (1)

Country Link
GB (1) GB201207102D0 (en)

Similar Documents

Publication Publication Date Title
HK1207304A1 (en) Crhr1 antagonists for use in the treatment of patients having crh overactivity crh crhr1
HK1216176A1 (en) Unsymmetrical pyrrolobenzodiazepines-dimers for use in the treatment of proliferative and autoimmune diseases
IL239355A0 (en) Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
IL229474A0 (en) Cannabinoids for use in the treatment of neuropatich pain
ZA201408056B (en) Compositions and methods for the treatment of mucositis
IL237125A0 (en) Niclosamide and its derivatives for use in the treatment of solid tumors
HK1207860A1 (en) 2-phenyl-5-heterocyclyl-tetrahydro-2h-pyran-3-amine compounds for use in the treatment of diabetes and its associated disorders 2--5---2h--3-
HK1204928A1 (en) Inhibitors of the notch signalling pathway and secretion for use in medicine notch
IL235127A (en) Hpn-100 for use in the treatment of nitrogen retention disorders
HK1213190A1 (en) Compounds for the treatment of obesity and methods of use thereof
HK1246694A1 (en) Use of thymosin alpha for the treatment of sepsis
EP2669279A4 (en) Bicyclic compound and use thereof for medical purposes
IL236823A0 (en) Compositions for use in the treatment of bone defects
ZA201501503B (en) Bio-inoculant and use thereof for treatment of effluents
ZA201408055B (en) Compositions and methods for the treatment of local pain
EP2669280A4 (en) Bicyclic compound and use thereof for medical purposes
GB2515440B (en) Vesicular Formulations for use in the treatment of Rosacea
LT2845598T (en) Preparation for use in the prophylaxis and treatment of atypical osteoporosis
PL2875026T3 (en) Imidazopyridine derivative used in the treatment of diabetes
IL235272B (en) Alfentanil composition for the treatment of acute pain
GB201207102D0 (en) CRHR1 antagonists for use in the treatment of patients having CRH overactivity
LT2863932T (en) Composition for use in the treatment of lymphedema
GB201208770D0 (en) Compounds for use in the treatment of adenovirus infections
GB201223371D0 (en) Novel mucinase for use in therapy or prophylaxis

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)